This increased mortality risk may be driven by obesity‐related metabolic dysfunction, which exacerbates hepatic inflammation and fibrosis through mechanisms such as insulin resistance and adipokine dysregulation. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.